| Mr Avesahmed Bukhari, MD | |
|
10000 Bay Pines Blvd Bay Pines, Bay Pines, FL 33744-8200 | |
| (813) 205-2767 | |
| Not Available |
| Full Name | Mr Avesahmed Bukhari |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 10000 Bay Pines Blvd Bay Pines, Bay Pines, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760006001 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | E-16790 (Arkansas) | Primary |
| Entity Name | Ess Hospitalist Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881967305 PECOS PAC ID: 6103085295 Enrollment ID: O20120308000726 |
News Archive
Merck & Co., Inc. today announced financial results for the second quarter of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the second quarter of $0.86, which excludes purchase accounting adjustments, merger-related expenses, restructuring costs and the gain on AstraZeneca's asset option exercise. Second-quarter GAAP EPS was $0.24.
A soft, wearable device that mimics the muscles, tendons and ligaments of the lower leg could aid in the rehabilitation of patients with ankle-foot disorders such as drop foot, said Yong-Lae Park, an assistant professor of robotics at Carnegie Mellon University.
The study of an oxygen-sensing bacterial regulatory protein by chemistry researchers at the University of Georgia has provided molecular insight into the oxygen sensing mechanism, which could ultimately lead to a better understanding of the ageing process and new treatments for human diseases such cancer, Parkinson's and Alzheimer's.
A new molecular test for tuberculosis can diagnose the disease and detect a drug-resistant form of it in less than two hours and more accurately than current tests, according to the findings of a study published online in the New England Journal of Medicine on Wednesday, Reuters reports (Kelland, 9/1).
Xcellerex, Inc. and Itero Biopharmaceuticals, Inc. announced today that they have signed a Letter of Intent to enter into a strategic collaboration for the production of Itero's lead product, an undisclosed commercially differentiated therapeutic protein. Itero will initiate technology transfer for the product to Xcellerex immediately.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Avesahmed Bukhari, MD 10000 Bay Pines Blvd Bay Pines, Baypines, FL 33744 Ph: (727) 398-6661 | Mr Avesahmed Bukhari, MD 10000 Bay Pines Blvd Bay Pines, Bay Pines, FL 33744-8200 Ph: (813) 205-2767 |
News Archive
Merck & Co., Inc. today announced financial results for the second quarter of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the second quarter of $0.86, which excludes purchase accounting adjustments, merger-related expenses, restructuring costs and the gain on AstraZeneca's asset option exercise. Second-quarter GAAP EPS was $0.24.
A soft, wearable device that mimics the muscles, tendons and ligaments of the lower leg could aid in the rehabilitation of patients with ankle-foot disorders such as drop foot, said Yong-Lae Park, an assistant professor of robotics at Carnegie Mellon University.
The study of an oxygen-sensing bacterial regulatory protein by chemistry researchers at the University of Georgia has provided molecular insight into the oxygen sensing mechanism, which could ultimately lead to a better understanding of the ageing process and new treatments for human diseases such cancer, Parkinson's and Alzheimer's.
A new molecular test for tuberculosis can diagnose the disease and detect a drug-resistant form of it in less than two hours and more accurately than current tests, according to the findings of a study published online in the New England Journal of Medicine on Wednesday, Reuters reports (Kelland, 9/1).
Xcellerex, Inc. and Itero Biopharmaceuticals, Inc. announced today that they have signed a Letter of Intent to enter into a strategic collaboration for the production of Itero's lead product, an undisclosed commercially differentiated therapeutic protein. Itero will initiate technology transfer for the product to Xcellerex immediately.
› Verified 9 days ago
Dr. Daniel Leiding, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10000 Bay Pines Blvd, Bay Pines, FL 33744 Phone: 727-398-6661 Fax: 727-398-9557 | |
Lan Ngoc Van, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10000 Bay Pines Blvd, Bay Pines, FL 33744 Phone: 727-398-6661 | |
Lawrence Alan Gaulkin, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 10000 Bay Pines Blvd, Bay Pines, FL 33744 Phone: 727-398-6661 | |
Dr. Shawna Marie Kubasky, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 10000 Bay Pines Blvd, Bay Pines, FL 33744 Phone: 727-398-6661 | |
Dr. Eddie Andre Ariss, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 10000 Bay Pines Blvd, Emergency Department, Bay Pines, FL 33744 Phone: 727-398-6661 Fax: 727-398-9557 | |
Dr. Jennifer Loyola Cabreira-steimle, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 10000 Bay Pines Blvd, Bay Pines, FL 33744 Phone: 727-398-6661 | |
Brian Leo Taylor, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10000 Bay Pines Blvd, Bay Pines, FL 33744 Phone: 727-398-6661 |